Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Report Guidance 4 Clinical Trials by Region 5 Clinical Trials and Average Enrollment by Country 6 Top Countries Contributing to Clinical Trials in Asia-Pacific 8 Top Countries Contributing to Clinical Trials in Europe 9 Top Countries Contributing to Clinical Trials in North America 10 Clinical Trials by G7 Countries: Proportion of Tetralogy Of Fallot to Cardiovascular Clinical Trials 11 Clinical Trials by Phase in G7 Countries 12 Clinical Trials in G7 Countries by Trial Status 13 Clinical Trials by E7 Countries: Proportion of Tetralogy Of Fallot to Cardiovascular Clinical Trials 14 Clinical Trials by Phase 15 Clinical Trials by Trial Status 16 Clinical Trials by End Point Status 17 Clinical Trials by Sponsor Type 18 Prominent Sponsors 19 Prominent Drugs 20 Clinical Trial Profile Snapshots 21 Appendix 26 Abbreviations 26 Definitions 26 Research Methodology 27 Secondary Research 27 About GlobalData 28 Contact Us 28 Disclaimer 28 Source 29

List of Tables Tetralogy Of Fallot Therapeutics, Global, Clinical Trials by Region, 2016* 5 Tetralogy Of Fallot Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Tetralogy Of Fallot Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7 Tetralogy Of Fallot Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8 Tetralogy Of Fallot Therapeutics Clinical Trials, Europe, Top Countries, 2016* 9 Tetralogy Of Fallot Therapeutics Clinical Trials, North America, Top Countries, 2016* 10 Proportion of Tetralogy Of Fallot to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 11 Tetralogy Of Fallot Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12 Tetralogy Of Fallot Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13 Proportion of Tetralogy Of Fallot to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 14 Tetralogy Of Fallot Therapeutics, Global, Clinical Trials by Phase, 2016* 15 Tetralogy Of Fallot Therapeutics, Global, Clinical Trials by Trial Status, 2016* 16 Tetralogy Of Fallot Therapeutics Clinical Trials, Global, by End Point Status, 2016* 17 Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 18 Tetralogy Of Fallot Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 19 Tetralogy Of Fallot Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 20 List of Figures Tetralogy Of Fallot Therapeutics, Global, Clinical Trials by Region (%), 2016* 5 Tetralogy Of Fallot Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Tetralogy Of Fallot Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7 Tetralogy Of Fallot Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 9 Proportion of Tetralogy Of Fallot to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 11 Tetralogy Of Fallot Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12 Tetralogy Of Fallot Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13 Proportion of Tetralogy Of Fallot to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 14 Tetralogy Of Fallot Therapeutics, Global, Clinical Trials by Phase (%), 2016* 15 Tetralogy Of Fallot Therapeutics, Global, Clinical Trials by Trial Status, 2016* 16 Tetralogy Of Fallot Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 18 Tetralogy Of Fallot Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 19 Tetralogy Of Fallot Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 20 GlobalData Methodology 27

Pfizer Inc.